Cilta-cel is a special type of treatment using CAR-T therapy, where a patient's own cells are changed to fight cancer cells. This study looks at how safe cilta-cel is over a long time. It follows patients who have already had cilta-cel treatment to check for any long-term side effects or problems. The study lasts up to 15 years, with check-ups at least once a year. During these check-ups, doctors will review any side effects, do lab tests, and physical exams, including checking the brain and nerves.
- Study follows up to 15 years.
- No new treatment is given during the study.
- Visits are needed at least once per year.
To join this study, you must have already received at least one dose of cilta-cel in a company-sponsored study and agreed to participate by signing a consent form.